- they are sitting on groundbreaking tech - have a great product which integrates with a number of key hospital platforms - have had independent research confirm the efficacy of APAS - they have announced multiple times to market that FDA MSRA approval and US distributor deal expected within next 3 weeks of trading (not a long time to wait for a return) - these announcements are likely to see at least a 50% increase in SP in the immediate term with a serious relate warranted (all IMO )
and yet the SP is going down. clearly the whole market doesn't trust what BB is saying. it is an extraordinary situation.
LBT Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
